Improving the differential diagnosis between myelodysplastic syndromes and reactive peripheral cytopenias by multiparametric flow cytometry: the role of B-cell precursors

Kappa and lambda light chain mRNA in situ hybridization compared to flow cytometry and immunohistochemistry in B cell lymphomas

(2014) Lisa M Rimsza et al.   Diagnostic Pathology

Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood

(2014) A. M. Aalbers et al.   HAEMATOLOGICA

Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes—proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS

(2014) A Porwit et al.   LEUKEMIA

Combined flow cytometric assessment of CD45, HLA-DR, CD34, and CD117 expression is a useful approach for reliable quantification of blast cells in myelodysplastic syndromes

(2013) Alex F. Sandes et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Diagnostic application and clinical significance of FCM progress scoring system based on immunophenotyping in CD34+ blasts in myelodysplastic syndromes

(2013) Feng Xu et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Hematogones: An overview

(2013) S.P. Chantepie et al.   LEUKEMIA RESEARCH

Immunophenotyping in Myelodysplastic Syndromes Can Add Prognostic Information to Well-Established and New Clinical Scores

(2013) Suiellen C. Reis-Alves et al.   PLoS One

Revised International Prognostic Scoring System for Myelodysplastic Syndromes

(2012) P. L. Greenberg et al.   BLOOD

MiR-34b is associated with clinical outcome in triple-negative breast cancer patients

(2012) Marek Svoboda et al.   Diagnostic Pathology

Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study

(2012) M. G. Della Porta et al.   HAEMATOLOGICA

New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge

(2012) Julie Schanz et al.   JOURNAL OF CLINICAL ONCOLOGY

Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group

(2012) T M Westers et al.   LEUKEMIA

Differences in blast immunophenotypes among disease types in myelodysplastic syndromes: A multicenter validation study

(2012) Kiyoyuki Ogata et al.   LEUKEMIA RESEARCH

Multi-color CD34+ progenitor-focused flow cytometric assay in evaluation of myelodysplastic syndromes in patients with post cancer therapy cytopenia

(2012) Guilin Tang et al.   LEUKEMIA RESEARCH

Review of the relevance of aberrant antigen expression by flow cytometry in myeloid neoplasms

(2011) Gert J. Ossenkoppele et al.   BRITISH JOURNAL OF HAEMATOLOGY

Prognostic relevance of cytometric quantitative assessment in patients with myelodysplastic syndromes

(2011) Patrizia Falco et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)

(2011) L. Malcovati et al.   HAEMATOLOGICA

Flow cytometric scoring system as a diagnostic and prognostic tool in myelodysplastic syndromes

(2011) Sung-Chao Chu et al.   LEUKEMIA RESEARCH

Implementation of flow cytometry in the diagnostic work-up of myelodysplastic syndromes in a multicenter approach: Report from the Dutch Working Party on Flow Cytometry in MDS

(2011) Theresia M. Westers et al.   LEUKEMIA RESEARCH

Clinical utility of multiparameter flow cytometry in the diagnosis of 1013 patients with suspected myelodysplastic syndrome

(2010) Wolfgang Kern et al.   CANCER

The impact of several phenotypic features at diagnosis on survival of patients with myelodysplastic syndromes

(2010) S. REIS-ALVES et al.   NEOPLASMA

Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes

(2009) A. A. van de Loosdrecht et al.   HAEMATOLOGICA

Myelodysplastic syndromes: the role of flow cytometry in diagnosis and prognosis

(2009) M. STETLER-STEVENSON et al.   International Journal of Laboratory Hematology

VARIATION OF BONE MARROW CD34+ CELL SUBSETS IN MYELODYSPLASTIC SYNDROMES ACCORDING TO WHO TYPES

(2009) S. REIS et al.   NEOPLASMA

The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors

(2008) S Matarraz et al.   LEUKEMIA

Flow cytometric parameters with little interexaminer variability for diagnosing low-grade myelodysplastic syndromes

(2008) Chikako Satoh et al.   LEUKEMIA RESEARCH

Flow cytometry in myelodysplastic syndromes: Report from a working conference

(2007) Michael R. Loken et al.   LEUKEMIA RESEARCH

The prognostic value of maturation-associated phenotypic abnormalities in myelodysplastic syndromes

(2007) I. Lorand-Metze et al.   LEUKEMIA RESEARCH

Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: Emphasis on a global evaluation and recognition of diagnostic pitfalls

(2007) Dariusz Stachurski et al.   LEUKEMIA RESEARCH